Respiratorius AB (FRA:HF00) Days Payable: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HF00 Respiratorius AB FRA:HF00
34 GF Score
Price €0.27
View Full Analysis

What is Respiratorius AB Days Payable?

Respiratorius AB FRA:HF00 34 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates FRA:HF00 with a GF Score™ of 34/100. Among 701 Biotechnology companies, Respiratorius AB ranks worse than 142653.21% on this metric.

Respiratorius AB's average Accounts Payable for the three months ended in Mar. 2026 was €0.10 Mil. Respiratorius AB's Cost of Goods Sold for the three months ended in Mar. 2026 was €-0.10 Mil.

The historical rank and industry rank for Respiratorius AB's Days Payable or its related term are showing as below:

During the past 13 years, Respiratorius AB's highest Days Payable was 32748.61. The lowest was 32748.61. And the median was 32748.61.

FRA:HF00's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Respiratorius AB's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Respiratorius AB Days Payable Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Days Payable Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 26,462.50

Respiratorius AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:HF00 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Respiratorius AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Respiratorius AB Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's Days Payable falls into.


FRA:HF00
34GF Score
Respiratorius AB FRA:HF00
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Respiratorius AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.048 + 0.097) / 2 ) / 0.001*365
=0.0725 / 0.001*365
=26,462.50

Respiratorius AB's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.097 + 0) / 1 ) / -0.103*365 / 4
=0.097 / -0.103*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Respiratorius AB (FRA:HF00) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Respiratorius AB and its competitors. Over the past decade, Respiratorius AB's Days Payable has ranged from 32,748.61 to 32,748.61. According to the industry distribution chart, Respiratorius AB ranks #999999 out of 701 companies in the Biotechnology industry.
Is Respiratorius AB's Days Payable too high?
Respiratorius AB's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 32,748.61 to a high of 32,748.61. Based on the distribution chart, Respiratorius AB ranks #999999 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Respiratorius AB has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Respiratorius AB's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Respiratorius AB ranks #999999 out of 701 companies for Days Payable. This places Respiratorius AB in the lower half of its industry. The industry median Days Payable is 112.84. Historically, Respiratorius AB's own Days Payable has ranged from 32,748.61 to 32,748.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Respiratorius AB and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Respiratorius AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Respiratorius AB stock overvalued right now?
Respiratorius AB (FRA:HF00) has a current Days Payable of 0.00. The current Days Payable is 0.00. Respiratorius AB's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Respiratorius AB (FRA:HF00), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Respiratorius AB Business Description

Other Exchanges RESP:Sweden
Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
34GF Score

Get the complete analysis for FRA:HF00

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price